A study using a PET scan tracer developed at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital (MGH) has identified, for the first time, epigenetic differences between the brains of individuals with schizophrenia and those of unaffected study participants.  {read more here}

Artificial intelligence (AI) can generate high-quality amyloid PET images from simultaneously acquired MR images and ultra-low-dose PET data, according to a Dec. 11, 2018 published in Radiology. {read more here}

New research on prostate cancer staging shows that PSMA-targeted PET/MRI performs equally as well as currently used predictive tools to determine the risk for advanced disease. The first-of-its-kind study, published in the December issue of The Journal of Nuclear Medicine, purports that whole-body imaging with 68Ga-PSMA-11 PET/MRI could be advantageous for physicians, as it offers information to guide treatment options for prostate cancer patients. {read more here}

…researchers from the Penn’s department of Radiology and the Abramson Cancer Center used PET imaging and a novel radioactive tracer known as [18F]FluorThanatrace (FTT), to measure PARP-1 levels in 30 women with breast cancer with various subtypes before therapy, including surgery. They found that the PET imaging agent could effectively visualize and measure PARP-1 levels in all breast cancer tumors and metastases. {read more here}